Cosmo Bio CompanyLimited Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Norihiko Shibayama
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.9% |
| Management average tenure | no data |
| Board average tenure | 2.8yrs |
Recent management updates
Recent updates
Cosmo Bio CompanyLimited's (TSE:3386) Shareholders Have More To Worry About Than Only Soft Earnings
Aug 12
Cosmo Bio CompanyLimited (TYO:3386) Is Experiencing Growth In Returns On Capital
May 09Cosmo Bio Company,Limited (TYO:3386) Vies For A Place In Your Dividend Portfolio: Here's Why
Mar 23Cosmo Bio Company,Limited's (TYO:3386) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 02Will The ROCE Trend At Cosmo Bio CompanyLimited (TYO:3386) Continue?
Feb 07
Does Cosmo Bio CompanyLimited's (TYO:3386) Share Price Gain of 30% Match Its Business Performance?
Jan 17Should Cosmo Bio Company,Limited (TYO:3386) Be Part Of Your Dividend Portfolio?
Dec 23Do Fundamentals Have Any Role To Play In Driving Cosmo Bio Company,Limited's (TYO:3386) Stock Up Recently?
Dec 02CEO
Norihiko Shibayama (55 yo)
less than a year
Tenure
Norihiko Shibayama serves as President at Cosmo Bio Company, Limited since 2024 and also served as its Senior Managing Director since March 23, 2023 until 2024 and serves as its Director and Chairman and a...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Chairman | no data | no data | 0.87% ¥ 57.0m | |
| GM of Finance Department & Director | 1.8yrs | no data | no data | |
| MD, Planning Department Manager & Director | no data | no data | 0.20% ¥ 12.9m | |
| Independent Outside Director | 2.8yrs | no data | no data | |
| Independent External Director | 10.8yrs | no data | no data | |
| Independent Outside Director | 2.8yrs | no data | no data | |
| Independent Outside Director | less than a year | no data | no data |
2.8yrs
Average Tenure
55yo
Average Age
Experienced Board: 3386's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 09:36 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cosmo Bio Company,Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|